{kanada_flagge}India is experiencing a major shortage of healthcare professionals. Predictmedix AI (CSE: PMED, / WKN A3EQWJ) will help alleviate this by deploying its advanced AI solutions for healthcare. What speaks in favor of using the solutions developed by Predictmedix, among other things, is that they are contactless and integrative. This could improve efficiency, accuracy and safety in the country’s healthcare system.
{kanada_flagge}India is experiencing a major shortage of healthcare professionals. Predictmedix AI (CSE: PMED, / WKN A3EQWJ) will help alleviate this by deploying its advanced AI solutions for healthcare. What speaks in favor of using the solutions developed by Predictmedix, among other things, is that they are contactless and integrative. This could improve efficiency, accuracy and safety in the country’s healthcare system.
There are only 64 doctors per 100,000 inhabitants in India. This means that the rate of medical care on the subcontinent is far below the global average, which is 150 doctors per 100,000 inhabitants. This considerable discrepancy cannot be eliminated overnight through the traditional training of doctors and other medical professionals.
Therefore, there is a particularly strong need in India for innovative solutions that can close this gap in healthcare. Not only for India, but especially for countries like India, the innovative solutions of Predictmedix AI are therefore of particular importance, because they eliminate the need for physical contact and thus contribute to the overall improvement of healthcare.
Predictmedix’s non-contact, integrative AI solutions combine computer imaging, thermal imaging and predictive analytics to enable seamless and efficient healthcare interactions. For example, capabilities offered include non-contact temperature screening, symptom analysis, mental health assessment, and substance abuse detection.
Conclusion: By using sophisticated algorithms, Predictmedix AI ensures accurate and reliable results that provide valuable insights for healthcare providers to make informed decisions. For the Indian healthcare system, the solutions provided by Predictmedix AI represent, as CEO Dr. Rahul Kushwah stated, “a significant leap forward in medical diagnostics and screening.”
To develop the Indian market, Predictmedix will establish its own Indian subsidiary. It will be named Predictmedix India Pvt Ltd and will work with government institutions and industry representatives to improve healthcare outcomes for the country’s population.
Disclaimer: GOLDINVEST Consulting GmbH publishes comments, analyses and news on https://goldinvest.de. These contents are exclusively for the information of the readers and do not represent a call to action, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. Furthermore, they are in no way a substitute for individual expert investment advice and do not constitute an offer to sell the discussed stock(s) or a solicitation to buy or sell securities. It is expressly not a financial analysis, but a promotional/journalistic text. Readers who make investment decisions or execute transactions on the basis of the information provided here do so exclusively at their own risk. There is no contractual relationship between GOLDINVEST Consulting GmbH and its readers or the users of its offers, because our information refers only to the company, but not to the investment decision of the reader.
The acquisition of securities is associated with high risks, which can lead to a total loss of the invested capital. The information published by GOLDINVEST Consulting GmbH and its authors is based on careful research. Nevertheless, any liability for financial losses or the content guarantee for topicality, correctness, adequacy and completeness of the articles offered here is expressly excluded. Please also note our terms of use.
Pursuant to §34b WpHG and §48f Abs. 5 BörseG (Austria) we point out that GOLDINVEST Consulting GmbH and/or partners, principals or employees of GOLDINVEST Consulting GmbH hold shares in Predictmedix and therefore a conflict of interest exists. GOLDINVEST Consulting GmbH also reserves the right to buy or sell shares of the company at any time. Furthermore, GOLDINVEST Consulting GmbH is remunerated by Predictmedix for reporting on the company. This is another clear conflict of interest.
